| Ticker | ZNTL |
|---|---|
| ISIN | US98943L1070 |
| Sector | Tecnología |
| Mercado | NASDAQ |
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; Phase 1/2 clinical trial for the treatment of advanced solid tumors as a monotherapy and in an ongoing Phase 1b clinical trial in combination ...
El precio actual de Zentalis Pharmaceuticals, Inc (ZNTL) es de 4,07 , con una variación del 2,26%.
Zentalis Pharmaceuticals, Inc opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones